214 related articles for article (PubMed ID: 32619863)
1. Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.
Massi D; Mihic-Probst D; Schadendorf D; Dummer R; Mandalà M
Cancer Treat Rev; 2020 Aug; 88():102060. PubMed ID: 32619863
[TBL] [Abstract][Full Text] [Related]
2. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
3. Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.
Țăpoi DA; Gheorghișan-Gălățeanu AA; Dumitru AV; Ciongariu AM; Furtunescu AR; Marin A; Costache M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373134
[TBL] [Abstract][Full Text] [Related]
4. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation.
Landsberg J; Kohlmeyer J; Renn M; Bald T; Rogava M; Cron M; Fatho M; Lennerz V; Wölfel T; Hölzel M; Tüting T
Nature; 2012 Oct; 490(7420):412-6. PubMed ID: 23051752
[TBL] [Abstract][Full Text] [Related]
5. Primary de-differentiated, trans-differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum.
Ferreira I; Arends MJ; van der Weyden L; Adams DJ; Brenn T
Histopathology; 2022 Jan; 80(1):135-149. PubMed ID: 34958502
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria.
Agaimy A; Stoehr R; Hornung A; Popp J; Erdmann M; Heinzerling L; Hartmann A
Am J Surg Pathol; 2021 Feb; 45(2):240-254. PubMed ID: 33428337
[TBL] [Abstract][Full Text] [Related]
7. Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.
Kasago IS; Chatila WK; Lezcano CM; Febres-Aldana CA; Schultz N; Vanderbilt C; Dogan S; Bartlett EK; D'Angelo SP; Tap WD; Singer S; Ladanyi M; Shoushtari AN; Busam KJ; Hameed M
Mod Pathol; 2023 Aug; 36(8):100165. PubMed ID: 36990277
[TBL] [Abstract][Full Text] [Related]
8. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
[TBL] [Abstract][Full Text] [Related]
9. Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.
Granados K; Poelchen J; Novak D; Utikal J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167306
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy.
Prior L; Toomey S; Greally M; Keane F; Lim M; Harrold E; O'Keane C; Bulger K; Hennessy BT; Furney SJ; McCaffrey J
Melanoma Res; 2020 Apr; 30(2):213-218. PubMed ID: 31425481
[TBL] [Abstract][Full Text] [Related]
11. Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis.
Hench J; Mihic-Probst D; Agaimy A; Frank S; Meyer P; Hultschig C; Simi S; Alos L; Balamurugan T; Blokx W; Bosisio F; Cappellesso R; Griewank K; Hadaschik E; van Kempen LC; Kempf W; Lentini M; Mazzucchelli L; Rinaldi G; Rutkowski P; Schadendorf D; Schilling B; Szumera-Cieckiewicz A; van den Oord J; Mandalà M; Massi D;
Eur J Cancer; 2023 Jul; 187():7-14. PubMed ID: 37098294
[TBL] [Abstract][Full Text] [Related]
12. De- and re-differentiation of the melanocytic lineage.
Larribere L; Utikal J
Eur J Cell Biol; 2014; 93(1-2):30-5. PubMed ID: 24365127
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated and undifferentiated melanomas: a practical approach to a challenging diagnosis.
Wiedemeyer K; Brenn T
Hum Pathol; 2023 Oct; 140():22-31. PubMed ID: 37001740
[TBL] [Abstract][Full Text] [Related]
14. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B
J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation in Melanoma: Facts and Hopes.
Giunta EF; Arrichiello G; Curvietto M; Pappalardo A; Bosso D; Rosanova M; Diana A; Giordano P; Petrillo A; Federico P; Fabozzi T; Parola S; Riccio V; Mucci B; Vanella V; Festino L; Daniele B; Ascierto PA; Ottaviano M; On Behalf Of Scito Youth
Cells; 2021 Aug; 10(8):. PubMed ID: 34440824
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of melanoma: implications for immune-based therapies.
Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M
Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079
[TBL] [Abstract][Full Text] [Related]
17. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Rajkumar S; Watson IR
Br J Cancer; 2016 Jul; 115(2):145-55. PubMed ID: 27336610
[TBL] [Abstract][Full Text] [Related]
19. Highlights of the 2012 Congress of the Society for Melanoma Research, 8-11 November 2012, Hollywood, CA.
Vultur A; Webster M; Villanueva J; Herlyn D
Melanoma Res; 2013 Jun; 23(3):237-40. PubMed ID: 23546222
[TBL] [Abstract][Full Text] [Related]
20. Genetic pathways to melanoma tumorigenesis.
Hussein MR
J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
